PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Safety check: cuvitru under the microscope for immune deficiency patients
Knowledge-focused Recruiting nowThis study looks back at medical records of about 100 people in Japan with primary immunodeficiency who received Cuvitru. The goal is to track serious side effects like allergic reactions, blood clots, and meningitis. No new treatment is given—researchers are simply analyzing exi…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Lab study explores new ways to treat rare immune diseases
Knowledge-focused Recruiting nowThis study looks at how JAK-inhibitor drugs affect the immune system and tests a gene therapy approach in cells from patients with primary immunodeficiency diseases. Researchers will collect blood samples from 20 adults to measure immune cell changes and gene editing efficiency. …
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: NA • Sponsor: prof. dr. Rik Schrijvers • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC